Noam Pondé

2.2k total citations · 1 hit paper
52 papers, 1.4k citations indexed

About

Noam Pondé is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Noam Pondé has authored 52 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Noam Pondé's work include HER2/EGFR in Cancer Research (26 papers), Advanced Breast Cancer Therapies (15 papers) and Breast Cancer Treatment Studies (14 papers). Noam Pondé is often cited by papers focused on HER2/EGFR in Cancer Research (26 papers), Advanced Breast Cancer Therapies (15 papers) and Breast Cancer Treatment Studies (14 papers). Noam Pondé collaborates with scholars based in Belgium, Brazil and Italy. Noam Pondé's co-authors include Martine Piccart, Evandro de Azambuja, Matteo Lambertini, Dimitrios Zardavas, Marco Bruzzone, Marcello Ceppi, Lucia Del Mastro, Francesca Poggio, Mariana Brandão and Giovanni La Valle and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Noam Pondé

48 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis

2018 303 citations Francesca Poggio, Marco Bruzzone et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Noam Pondé Belgium	19	981	488	372	324	212	52	1.4k
Jutta Steinseifer Switzerland	10	990 1.0×	484 1.0×	495 1.3×	526 1.6×	212 1.0×	15	1.5k
Cecilia Nisticò Italy	23	1.2k 1.2×	555 1.1×	403 1.1×	306 0.9×	166 0.8×	70	1.6k
Linnea Chap United States	13	1.0k 1.1×	417 0.9×	367 1.0×	662 2.0×	137 0.6×	28	1.7k
Filipa Lynce United States	21	1.3k 1.3×	474 1.0×	456 1.2×	571 1.8×	146 0.7×	110	1.9k
Sònia Pernas Spain	20	1.1k 1.1×	545 1.1×	447 1.2×	413 1.3×	312 1.5×	109	1.6k
Raquel Nunes United States	14	816 0.8×	333 0.7×	164 0.4×	171 0.5×	303 1.4×	38	1.1k
Kristi McIntyre United States	16	1.6k 1.6×	959 2.0×	405 1.1×	328 1.0×	99 0.5×	39	1.9k
Lourdes Calvo Spain	23	1.2k 1.2×	1.1k 2.2×	344 0.9×	518 1.6×	116 0.5×	102	2.0k
Cristiano Ferrario Canada	18	1.3k 1.3×	653 1.3×	515 1.4×	476 1.5×	208 1.0×	81	1.9k
Mariantonietta Colozza Italy	19	1.0k 1.0×	472 1.0×	304 0.8×	360 1.1×	233 1.1×	36	1.4k

Countries citing papers authored by Noam Pondé

Since Specialization

Citations

This map shows the geographic impact of Noam Pondé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noam Pondé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noam Pondé more than expected).

Fields of papers citing papers by Noam Pondé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noam Pondé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noam Pondé. The network helps show where Noam Pondé may publish in the future.

Co-authorship network of co-authors of Noam Pondé

This figure shows the co-authorship network connecting the top 25 collaborators of Noam Pondé. A scholar is included among the top collaborators of Noam Pondé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noam Pondé. Noam Pondé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Agostinetto, Elisa, Lieveke Ameye, Samuel Martel, et al.. (2022). PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer. npj Breast Cancer. 8(1). 87–87. 9 indexed citations

Eiger, Daniel, Noam Pondé, Dominique Agbor‐Tarh, et al.. (2020). Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial. British Journal of Cancer. 122(10). 1453–1460. 23 indexed citations

Sonnenblick, Amir, Mali Salmon‐Divon, Roberto Salgado, et al.. (2020). Reactive stroma and trastuzumab resistance in HER2‐positive early breast cancer. International Journal of Cancer. 147(1). 266–276. 15 indexed citations

Sirohi, Bhawna, Noam Pondé, Mariana Brandão, et al.. (2020). 8P Knowledge, practice and attitudes of physicians in low- and middle-income countries (LMIC) on fertility and pregnancy-related issues in young breast cancer patients. Annals of Oncology. 31. S1245–S1245. 1 indexed citations

Pondé, Noam, et al.. (2019). Targeted therapy for breast cancer in older patients. Journal of Geriatric Oncology. 11(3). 380–388. 11 indexed citations

Eiger, Daniel, Noam Pondé, & Evandro de Azambuja. (2019). Pertuzumab In Her2-Positive Early Breast Cancer: Current Use And Perspectives. Future Oncology. 15(16). 1823–1843. 12 indexed citations

Eiger, Daniel, Noam Pondé, Dominique Agbor‐Tarh, et al.. (2019). Long-term cardiac outcomes of HER2+ breast cancer patients treated in the ALTTO trial. Annals of Oncology. 30. iii65–iii65. 2 indexed citations

Sonnenblick, Amir, David Venet, Sylvain Brohée, Noam Pondé, & Christos Sotiriou. (2019). pAKT pathway activation is associated with PIK3CA mutations and good prognosis in luminal breast cancer in contrast to p-mTOR pathway activation. npj Breast Cancer. 5(1). 7–7. 17 indexed citations

Azambuja, Evandro de, Noam Pondé, Marion Procter, et al.. (2019). A pooled analysis of the cardiac events in the trastuzumab adjuvant trials. Breast Cancer Research and Treatment. 179(1). 161–171. 40 indexed citations

10.

Pondé, Noam, et al.. (2018). Treatment of advanced HER2-positive breast cancer: 2018 and beyond. Cancer Treatment Reviews. 67. 10–20. 103 indexed citations

11.

Poggio, Francesca, Marco Bruzzone, Marcello Ceppi, et al.. (2018). Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis. Annals of Oncology. 29(7). 1497–1508. 303 indexed citations breakdown →

12.

Pondé, Noam, Dimitrios Zardavas, & Martine Piccart. (2018). Progress in adjuvant systemic therapy for breast cancer. Nature Reviews Clinical Oncology. 16(1). 27–44. 196 indexed citations

13.

Martel, Samuel, Marco Bruzzone, Marcello Ceppi, et al.. (2017). Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis. Cancer Treatment Reviews. 62. 123–132. 17 indexed citations

14.

Tutt, Andrew, Bella Kaufman, Judy E. Garber, et al.. (2017). OlympiA: A randomized phase III trial of olaparib as adjuvant therapy in patients with high-risk HER2-negative breast cancer (BC) and a germline BRCA1/2 mutation (gBRCAm). Annals of Oncology. 28. v67–v67. 16 indexed citations

15.

Lambertini, Matteo, et al.. (2017). Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer. Current Treatment Options in Oncology. 18(1). 4–4. 21 indexed citations

16.

Lambertini, Matteo, Noam Pondé, Cinzia Solinas, & Evandro de Azambuja. (2016). Adjuvant trastuzumab: a 10-year overview of its benefit. Expert Review of Anticancer Therapy. 17(1). 61–74. 46 indexed citations

17.

Sonnenblick, Amir, Noam Pondé, & Martine Piccart. (2016). Metastatic breast cancer: The Odyssey of personalization. Molecular Oncology. 10(8). 1147–1159. 16 indexed citations

18.

Pondé, Noam, Felipe Ades, & Evandro de Azambuja. (2016). Threat posed by unproven drugs in medical oncology. ESMO Open. 1(3). e000064–e000064. 1 indexed citations

19.

Piccart, Martine & Noam Pondé. (2016). Cancer drugs, survival and ethics: a critical look from the inside. ESMO Open. 1(6). esmoopen–2016. 4 indexed citations

20.

Pondé, Noam, Lissandra Dal Lago, & Hatem A. Azim. (2016). Adjuvant chemotherapy in elderly patients with breast cancer: key challenges. Expert Review of Anticancer Therapy. 16(6). 661–671. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact